The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015

Cancer Statistics, 2021

(2021) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

(2021) Carl M. Gay et al.   CANCER CELL

Small-cell lung cancer

(2021) Charles M. Rudin et al.   Nature Reviews Disease Primers

Morphological, immunohistochemical, and genetic analyses of bronchiolar adenoma and its putative variants

(2021) Jinchen Shao et al.   Journal of Pathology Clinical Research

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial

(2021) Ahmet Sezer et al.   LANCET

PD-L1 as a biomarker of response to immune-checkpoint inhibitors

(2021) Deborah Blythe Doroshow et al.   Nature Reviews Clinical Oncology

Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples

(2021) Katharina Kriegsmann et al.   BMC CANCER

Comprehensive Molecular and Clinicopathologic Analysis of 200 Pulmonary Invasive Mucinous Adenocarcinomas Identifies Distinct Characteristics of Molecular Subtypes

(2021) Jason C. Chang et al.   CLINICAL CANCER RESEARCH

Invasive Mucinous Adenocarcinomas With Spatially Separate Lung Lesions: Analysis of Clonal Relationship by Comparative Molecular Profiling

(2021) Soo-Ryum Yang et al.   Journal of Thoracic Oncology

Ciliated muconodular papillary tumor/bronchiolar adenoma of the lung

(2021) Tzu-Hang Kao et al.   SEMINARS IN DIAGNOSTIC PATHOLOGY

EBUS-TBNA Cytological Samples for Comprehensive Molecular Testing in Non–Small Cell Lung Cancer

(2021) Roberto Martin-Deleon et al.   Cancers

Counting mitoses: SI(ze) matters!

(2021) Ian A. Cree et al.   MODERN PATHOLOGY

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS

(2020) K. Park et al.   ANNALS OF ONCOLOGY

Pulmonary Peripheral Glandular Papilloma and Mixed Squamous Cell and Glandular Papilloma Frequently Harbor the BRAF V600E Mutation

(2020) Dong‐Liang Lin et al.   HISTOPATHOLOGY

Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

(2020) Nasser H. Hanna et al.   JOURNAL OF CLINICAL ONCOLOGY

New Approaches to SCLC Therapy: From the Laboratory to the Clinic

(2020) John T. Poirier et al.   Journal of Thoracic Oncology

Genomic landscape of lung adenocarcinoma in East Asians

(2020) Jianbin Chen et al.   NATURE GENETICS

Specific genomic alterations in high grade pulmonary neuroendocrine tumours with carcinoid morphology

(2020) Jérôme Cros et al.   NEUROENDOCRINOLOGY

Non-small cell lung carcinomas with CTNNB1 (beta-catenin) mutations: A clinicopathological study of 26 cases

(2020) Vincent Thomas de Montpréville et al.   Annals of Diagnostic Pathology

Recent eUpdate to the ESMO Clinical Practice Guidelines on early and locally advanced non-small-cell lung cancer (NSCLC)

(2020) G. Pentheroudakis   ANNALS OF ONCOLOGY

The Genomic Landscape of SMARCA4 Alterations and Associations with Outcomes in Patients with Lung Cancer

(2020) Adam J Schoenfeld et al.   CLINICAL CANCER RESEARCH

Both the presence of a micropapillary component and the micropapillary predominant subtype predict poor prognosis after lung adenocarcinoma resection: a meta-analysis

(2020) Wei Wang et al.   Journal of Cardiothoracic Surgery

A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee

(2020) Andre L. Moreira et al.   Journal of Thoracic Oncology

The rare YAP1 subtype of Small Cell Lung Cancer revisited in a biobank of 39 Circulating Tumour Cell Patient Derived eXplant models (CDX): A brief report

(2020) Sarah M. Pearsall et al.   Journal of Thoracic Oncology

Lung carcinoids with high proliferative activity: Further support for the identification of a new tumor category in the classification of lung neuroendocrine neoplasms

(2020) M. Rubino et al.   LUNG CANCER

Lung-only melanoma: UV mutational signature supports origin from occult cutaneous primaries and argues against the concept of primary pulmonary melanoma

(2020) Chen Yang et al.   MODERN PATHOLOGY

The Effect of Advances in Lung-Cancer Treatment on Population Mortality

(2020) Nadia Howlader et al.   NEW ENGLAND JOURNAL OF MEDICINE

Multiple faces of pulmonary large cell neuroendocrine carcinoma: update with a focus on practical approach to diagnosis

(2020) Marina K. Baine et al.   Translational Lung Cancer Research

AKT1 Mutations in Peripheral Bronchiolar Papilloma

(2020) Eiichi Sasaki et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Small Cell Lung Carcinoma Subtypes Defined by ASCL1, NEUROD1, POU2F3 and YAP1: Comprehensive Immunohistochemical and Histopathologic Characterization

(2020) Marina K. Baine et al.   Journal of Thoracic Oncology

The Isoform Matters in NUT Carcinoma: A Diagnostic Pitfall of p40 Immunohistochemistry

(2020) Kohei Matsuda et al.   Journal of Thoracic Oncology

KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors

(2020) David S. Hong et al.   NEW ENGLAND JOURNAL OF MEDICINE

Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC

(2020) Roy S. Herbst et al.   NEW ENGLAND JOURNAL OF MEDICINE

Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer

(2020) Yi-Long Wu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Capmatinib in MET Exon 14–Mutated or MET-Amplified Non–Small-Cell Lung Cancer

(2020) Jürgen Wolf et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer

(2020) Alexander Drilon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bronchiolar Adenoma/Pulmonary Ciliated Muconodular Papillary Tumor

(2020) Hemlata Shirsat et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Gross Specimen Handling Procedures Do Not Impact the Occurrence of Spread Through Air Spaces (STAS) in Lung Cancer

(2020) Jasna Metovic et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Reassessing the SCLC Subtypes

(2020) Yasushi Yatabe   Journal of Thoracic Oncology

First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer

(2020) Alice T. Shaw et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genetic ancestry contributes to somatic mutations in lung cancers from admixed Latin American populations

(2020) Jian Carrot-Zhang et al.   Cancer Discovery

YAP1 Expression in SCLC Defines a Distinct Subtype With T-cell–Inflamed Phenotype

(2020) Taofeek K. Owonikoko et al.   Journal of Thoracic Oncology

Prognostic Impact of Tumor Spread Through Air Spaces in Non-small Cell Lung Cancers: a Meta-Analysis Including 3564 Patients

(2019) Huining Liu et al.   PATHOLOGY & ONCOLOGY RESEARCH

Genomic Signature of Driver Genes Identified by Target Next‐Generation Sequencing in Chinese Non‐Small Cell Lung Cancer

(2019) Shiwang Wen et al.   ONCOLOGIST

Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices

(2019) Natasha Rekhtman et al.   MODERN PATHOLOGY

Characterization, Prognosis, and Treatment of Patients With Metastatic Lung Carcinoid Tumors

(2019) Patrick Robelin et al.   Journal of Thoracic Oncology

Limited Resection is Associated With a Higher Risk of Locoregional Recurrence than Lobectomy in Stage I Lung Adenocarcinoma With Tumor Spread Through Air Spaces

(2019) Kyuichi Kadota et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry

(2019) J Mazières et al.   ANNALS OF ONCOLOGY

Consistency and reproducibility of next‐generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens

(2019) Pasquale Pisapia et al.   CANCER CYTOPATHOLOGY

Spread Through Air Spaces (STAS) Is Prognostic in Atypical Carcinoid, Large Cell Neuroendocrine Carcinoma, and Small Cell Carcinoma of the Lung

(2019) Rania G. Aly et al.   Journal of Thoracic Oncology

Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations

(2019) Michele Simbolo et al.   Journal of Thoracic Oncology

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

(2019) Tony S K Mok et al.   LANCET

Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma

(2019) Xin Hu et al.   Nature Communications

The Role of Histologic Grading and Ki-67 Index in Predicting Outcomes in Pulmonary Carcinoid Tumors

(2019) Josephine K.T. Dermawan et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Two cases of lung neuroendocrine carcinoma with carcinoid morphology

(2019) Kenji Inafuku et al.   Diagnostic Pathology

The 2019 WHO classification of tumours of the digestive system

(2019) Iris D. Nagtegaal et al.   HISTOPATHOLOGY

Classification and prognostic stratification of bronchopulmonary neuroendocrine neoplasms

(2019) Naomi Oka et al.   NEUROENDOCRINOLOGY

Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer

(2019) Matthew D. Hellmann et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Semiquantitative Scoring System May Allow Biopsy Diagnosis of Pulmonary Large Cell Neuroendocrine Carcinoma

(2019) Marina K Baine et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Genomic Underpinnings of Tumor Behavior in in situ and Early Lung Adenocarcinoma

(2019) Jun Qian et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Thoracic SMARCA4-deficient sarcomatoid tumors represent primarily smoking-related undifferentiated carcinomas rather than primary thoracic sarcomas

(2019) N. Rekhtman et al.   Journal of Thoracic Oncology

Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids

(2019) N. Alcala et al.   Nature Communications

PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee

(2019) Sylvie Lantuejoul et al.   Journal of Thoracic Oncology

Next generation sequencing of lung adenocarcinoma subtypes with intestinal differentiation reveals distinct molecular signatures associated with histomorphology and therapeutic options

(2019) Philipp Jurmeister et al.   LUNG CANCER

Bronchiolar Adenoma

(2018) Jason C. Chang et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Tumor Spread Through Air Spaces Identifies a Distinct Subgroup With Poor Prognosis in Surgically Resected Lung Pleomorphic Carcinoma

(2018) Shintaro Yokoyama et al.   CHEST

Presence of micropapillary and solid patterns are associated with nodal upstaging and unfavorable prognosis among patient with cT1N0M0 lung adenocarcinoma: a large-scale analysis

(2018) Yonggang Yuan et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Predictors of survival in 211 patients with stage IV pulmonary and gastroenteropancreatic mIBG positive neuroendocrine tumors treated with I-131 mIBG

(2018) Ari Kane et al.   JOURNAL OF NUCLEAR MEDICINE

NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018

(2018) Manisha H. Shah et al.   Journal of the National Comprehensive Cancer Network

New Insights into the Molecular Characteristics of Pulmonary Carcinoids and Large Cell Neuroendocrine Carcinomas, and the Impact on Their Clinical Management

(2018) Jules L Derks et al.   Journal of Thoracic Oncology

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors

(2018) Neal I. Lindeman et al.   Journal of Thoracic Oncology

Distinctive features of immunostaining and mutational load in primary pulmonary enteric adenocarcinoma: implications for differential diagnosis and immunotherapy

(2018) Ming Chen et al.   Journal of Translational Medicine

Feasibility of endobronchial ultrasound transbronchial needle aspiration for massively parallel next-generation sequencing in thoracic cancer patients

(2018) Simon R. Turner et al.   LUNG CANCER

Hyalinizing clear cell carcinoma of the bronchial glands: presentation of three cases and pathological comparisons with salivary gland counterparts and bronchial mucoepidermoid carcinomas

(2018) Manabu Takamatsu et al.   MODERN PATHOLOGY

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

(2018) Leena Gandhi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors

(2018) Julie George et al.   Nature Communications

STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS -Mutant Lung Adenocarcinoma

(2018) Ferdinandos Skoulidis et al.   Cancer Discovery

OUP accepted manuscript

(2018)   ANNALS OF ONCOLOGY

So-called “non-classic” ciliated Muconodular papillary tumors: a comprehensive comparison of the Clinicopathological and molecular features with classic ciliated Muconodular papillary tumors

(2018) Qiang Zheng et al.   HUMAN PATHOLOGY

Implications of the Eighth Edition of the TNM Proposal: Invasive vs. Total Tumor Size for the T Descriptor in Pathologic Stage I-IIA Lung Adenocarcinoma

(2018) Koji Kameda et al.   Journal of Thoracic Oncology

Lobectomy Is Associated with Better Outcomes than Sublobar Resection in Spread Through Air Spaces (STAS)–Positive T1 Lung Adenocarcinoma: A Propensity Score–Matched Analysis1

(2018) Takashi Eguchi et al.   Journal of Thoracic Oncology

An Integrative Analysis of Transcriptome and Epigenome Features of ASCL1–Positive Lung Adenocarcinomas

(2018) Naoya Miyashita et al.   Journal of Thoracic Oncology

Procedure-Specific Risk Prediction for Recurrence in Patients Undergoing Lobectomy or Sublobar Resection for Small (≤2 cm) Lung Adenocarcinoma: An International Cohort Analysis

(2018) Sarina Bains et al.   Journal of Thoracic Oncology

A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal

(2018) Guido Rindi et al.   MODERN PATHOLOGY

Unmet medical needs in pulmonary neuroendocrine (carcinoid) neoplasms

(2018) Eric Baudin et al.   NEUROENDOCRINOLOGY

EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes

(2018) Nicolas Marcoux et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinicopathologic profiling of lung carcinoids with a Ki67 index greater than 20%

(2018) Atsuko Kasajima et al.   NEUROENDOCRINOLOGY

Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer

(2018) Yasushi Yatabe et al.   Journal of Thoracic Oncology

Expanding the Molecular Characterization of Thoracic Inflammatory Myofibroblastic Tumors beyond ALK Gene Rearrangements

(2018) Jason C. Chang et al.   Journal of Thoracic Oncology

Histologic Subtype in Core Lung Biopsies of Early-Stage Lung Adenocarcinoma is a Prognostic Factor for Treatment Response and Failure Patterns After Stereotactic Body Radiation Therapy

(2017) Jonathan E. Leeman et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Use of Oncogenic Driver Mutations in Staging of Multiple Primary Lung Carcinomas: A Single-Center Experience

(2017) Ramsey Asmar et al.   Journal of Thoracic Oncology

Spread through Air Spaces (STAS) Is an Independent Predictor of Recurrence and Lung Cancer–Specific Death in Squamous Cell Carcinoma

(2017) Shaohua Lu et al.   Journal of Thoracic Oncology

Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities

(2017) Akihiko Yoshida et al.   MODERN PATHOLOGY

SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior

(2017) Jennifer L Sauter et al.   MODERN PATHOLOGY

Natural History of Localized and Locally Advanced Atypical Lung Carcinoids after Complete Resection: A Joined French-Italian Retrospective Multicenter Study

(2017) Francesca Marciello et al.   NEUROENDOCRINOLOGY

A case of anaplastic lymphoma kinase (ALK)-positive ciliated muconodular papillary tumor (CMPT) of the lung

(2017) Ryo Taguchi et al.   PATHOLOGY INTERNATIONAL

Distinctive pathological and clinical features of lung carcinoids with high proliferation index

(2017) Caterina Marchiò et al.   VIRCHOWS ARCHIV

Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies

(2017) Emmet J. Jordan et al.   Cancer Discovery

Differences between low and high grade fetal adenocarcinoma of the lung: a clinicopathological and molecular study

(2017) Jing Zhang et al.   Journal of Thoracic Disease

Minor Components of Micropapillary and Solid Subtypes in Lung Adenocarcinoma are Predictors of Lymph Node Metastasis and Poor Prognosis

(2016) Yue Zhao et al.   ANNALS OF SURGICAL ONCOLOGY

Biomarker Testing in Lung Carcinoma Cytology Specimens: A Perspective From Members of the Pulmonary Pathology Society

(2016) Sinchita Roy-Chowdhuri et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets

(2016) N. Rekhtman et al.   CLINICAL CANCER RESEARCH

Limited additive value of the Ki-67 proliferative index on patient survival in World Health Organization-classified pulmonary carcinoids

(2016) Dorian R A Swarts et al.   HISTOPATHOLOGY

KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung

(2016) David H. Hwang et al.   Journal of Thoracic Oncology

Frequent BRAF or EGFR Mutations in Ciliated Muconodular Papillary Tumors of the Lung

(2016) Tsugumasa Kamata et al.   Journal of Thoracic Oncology

The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer

(2016) William D. Travis et al.   Journal of Thoracic Oncology

Comprehensive Characterization of Oncogenic Drivers in Asian Lung Adenocarcinoma

(2016) Shiyong Li et al.   Journal of Thoracic Oncology

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

(2016) Peter Goldstraw et al.   Journal of Thoracic Oncology

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

(2016) Roy S Herbst et al.   LANCET

Dabrafenib plus trametinib in patients with previously treated BRAF V600E -mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial

(2016) David Planchard et al.   LANCET ONCOLOGY

Morphological and molecular approach to synchronous non-small cell lung carcinomas: impact on staging

(2016) Frank Schneider et al.   MODERN PATHOLOGY

Ciliated Muconodular Papillary Tumors of the Lung

(2015) Tsugumasa Kamata et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Prognostic Impact of Intra-alveolar Tumor Spread in Pulmonary Adenocarcinoma

(2015) Arne Warth et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids

(2015) M. E. Caplin et al.   ANNALS OF ONCOLOGY

A Prospective Clinical Trial of Telecytopathology for Rapid Interpretation of Specimens Obtained During Endobronchial Ultrasound–Fine Needle Aspiration

(2015) Matthew J. Bott et al.   ANNALS OF THORACIC SURGERY

Rapid on-site evaluation of EBUS-TBNA specimens of lymph nodes: Comparative analysis and recommendations for standardization

(2015) Susanne K. Jeffus et al.   CANCER CYTOPATHOLOGY

Preanalytic parameters in epidermal growth factor receptor mutation testing for non-small cell lung carcinoma: A review of cytologic series

(2015) Gilda da Cunha Santos et al.   CANCER CYTOPATHOLOGY

Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung

(2015) Hyo Sup Shim et al.   Journal of Thoracic Oncology

EGFR Mutation Testing Practices within the Asia Pacific Region: Results of a Multicenter Diagnostic Survey

(2015) Yasushi Yatabe et al.   Journal of Thoracic Oncology

Tumor Spread through Air Spaces is an Important Pattern of Invasion and Impacts the Frequency and Location of Recurrences after Limited Resection for Small Stage I Lung Adenocarcinomas

(2015) Kyuichi Kadota et al.   Journal of Thoracic Oncology

SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas

(2015) Francois Le Loarer et al.   NATURE GENETICS

Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring MET Mutations Causing Exon 14 Skipping

(2015) P. K. Paik et al.   Cancer Discovery

Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma

(2014) T. Nakaoku et al.   CLINICAL CANCER RESEARCH

MAP2K1 (MEK1) Mutations Define a Distinct Subset of Lung Adenocarcinoma Associated with Smoking

(2014) M. E. Arcila et al.   CLINICAL CANCER RESEARCH

Sample Features Associated with Success Rates in Population-Based EGFR Mutation Testing

(2014) Carolyn J. Shiau et al.   Journal of Thoracic Oncology

Ki-67 Antigen in Lung Neuroendocrine Tumors: Unraveling a Role in Clinical Practice

(2014) Giuseppe Pelosi et al.   Journal of Thoracic Oncology

ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: A comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features

(2014) Yunjian Pan et al.   LUNG CANCER

Comprehensive analysis of RET and ROS1 rearrangement in lung adenocarcinoma

(2014) Seung Eun Lee et al.   MODERN PATHOLOGY

Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer

(2014) Alice T. Shaw et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ciliated muconodular papillary tumor of the lung: A newly defined peripheral pulmonary tumor with conspicuous mucin pool mimicking colloid adenocarcinoma: A case report and review of literature

(2014) Hao-Wen Chuang et al.   PATHOLOGY INTERNATIONAL

The Influence of Rapid Onsite Evaluation on the Adequacy Rate of Fine-Needle Aspiration Cytology

(2013) Robert L. Schmidt et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Characteristics of Lung Cancers Harboring NRAS Mutations

(2013) K. Ohashi et al.   CLINICAL CANCER RESEARCH

Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients—Based on a hospital study in China

(2013) Z. Song et al.   EJSO

Grading the neuroendocrine tumors of the lung: an evidence-based proposal

(2013) G Rindi et al.   ENDOCRINE-RELATED CANCER

Correlation of Mutation Status and Survival with Predominant Histologic Subtype According to the New IASLC/ATS/ERS Lung Adenocarcinoma Classification in Stage III (N2) Patients

(2013) Prudence A. Russell et al.   Journal of Thoracic Oncology

The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations

(2013) Koji Tsuta et al.   LUNG CANCER

On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas

(2013) Lénaïg Mescam-Mancini et al.   LUNG CANCER

KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinoma

(2013) Natasha Rekhtman et al.   MODERN PATHOLOGY

Nkx2-1 Represses a Latent Gastric Differentiation Program in Lung Adenocarcinoma

(2013) Eric L. Snyder et al.   MOLECULAR CELL

HNF4α as a Marker for Invasive Mucinous Adenocarcinoma of the Lung

(2012) Masato Sugano et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Diagnosis of Lung Cancer in Small Biopsies and Cytology: Implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification

(2012) William D. Travis et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS-Mutant Cancers

(2012) S. Dogan et al.   CLINICAL CANCER RESEARCH

RETFusions Define a Unique Molecular and Clinicopathologic Subtype of Non–Small-Cell Lung Cancer

(2012) Rui Wang et al.   JOURNAL OF CLINICAL ONCOLOGY

EGFRmutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples

(2012) Gillian Ellison et al.   JOURNAL OF CLINICAL PATHOLOGY

Prognostic Significance of Predominant Histologic Pattern and Nuclear Grade in Resected Adenocarcinoma of the Lung: Potential Parameters for a Grading System

(2012) Jan H. von der Thüsen et al.   Journal of Thoracic Oncology

Validation of the IASLC/ATS/ERS Lung Adenocarcinoma Classification for Prognosis and Association with EGFR and KRAS Gene Mutations: Analysis of 440 Japanese Patients

(2012) Akihiko Yoshizawa et al.   Journal of Thoracic Oncology

Limited role of Ki-67 proliferative index in predicting overall short-term survival in patients with typical and atypical pulmonary carcinoid tumors

(2012) Ann E Walts et al.   MODERN PATHOLOGY

RET, ROS1 and ALK fusions in lung cancer

(2012) Kengo Takeuchi et al.   NATURE MEDICINE

Acquisition and Processing of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Specimens in the Era of Targeted Lung Cancer Chemotherapy

(2011) William Bulman et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Primary Pulmonary Myxoid Sarcoma With EWSR1-CREB1 Fusion

(2011) Khin Thway et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Clinical Characteristics of Patients With Lung Adenocarcinomas HarboringBRAFMutations

(2011) Paul K. Paik et al.   JOURNAL OF CLINICAL ONCOLOGY

Suitability of Thoracic Cytology for New Therapeutic Paradigms in Non-small Cell Lung Carcinoma: High Accuracy of Tumor Subtyping and Feasibility of EGFR and KRAS Molecular Testing

(2011) Natasha Rekhtman et al.   Journal of Thoracic Oncology

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

(2011) William D. Travis et al.   Journal of Thoracic Oncology

Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases

(2011) Akihiko Yoshizawa et al.   MODERN PATHOLOGY

Subtyping of Undifferentiated Non-small Cell Carcinomas in Bronchial Biopsy Specimens

(2010) Peh Sun Loo et al.   Journal of Thoracic Oncology

Refining the Diagnosis and EGFR Status of Non-small Cell Lung Carcinoma in Biopsy and Cytologic Material, Using a Panel of Mucin Staining, TTF-1, Cytokeratin 5/6, and P63, and EGFR Mutation Analysis

(2010) Andrew G. Nicholson et al.   Journal of Thoracic Oncology

Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western Population

(2009) S. J. Rodig et al.   CLINICAL CANCER RESEARCH

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

(2009) Tony S. Mok et al.   NEW ENGLAND JOURNAL OF MEDICINE